21974-51-6

Basic information

• Product Name: Phenol, 4-bromo-2-[[(2-hydroxyethyl)imino]methyl]-
• CAS NO: 21974-51-6
• Molecular Formula: C9H10BrNO2
• Molecular Weight: 244.088
• Mol File: 21974-51-6.mol

Chemical Properties

• CAS DataBase Reference: Phenol, 4-bromo-2-[[(2-hydroxyethyl)imino]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Phenol, 4-bromo-2-[[(2-hydroxyethyl)imino]methyl]-(21974-51-6)
• EPA Substance Registry System: Phenol, 4-bromo-2-[[(2-hydroxyethyl)imino]methyl]-(21974-51-6)

Safety Data

• Hazardous Substances Data: 21974-51-6(Hazardous Substances Data)

Upstream product

• 141-43-5 ethanolamine 
• 1761-61-1 5-bromosalicyclaldehyde 

Downstream Products

• 1426385-43-4 C₂₇H₁₉F₃N₂O₃ 
• 1217862-54-8 tert-butyl N-(5-bromo-2-hydroxybenzyl)-N-(2-hydroxyethyl)carbamate 
• 1181407-01-1 C₉H₁₂BrNO₂ 
• 1251156-08-7 [7-(6-aminopyridin-3-yl)-2,3-dihydro-1,4-benzoxazepin-4(5H)-yl][3-fluoro-2-methyl-4-(methylsulfonyl)-phenyl]methanone 
• 1251163-50-4 C₂₂H₂₁N₃O₄S 
• 1251152-97-2 C₂₆H₂₄FN₃O₄S 
• 1251150-14-7 C₂₅H₂₂FN₃O₄S 
• 1251154-79-6 (7-(1H-benz[d]imidazol-6-yl)-2,3-dihydrobenzo[f][1,4]oxazepin-4(5H)-yl)(3-methyl-4-(methylsulfonyl)phenyl)methanone 
• 1251153-95-3 C₂₄H₂₀BrN₃O₄S 
• 1251158-25-4 C₂₄H₂₀ClN₃O₄S 
• 1251162-42-1 C₂₆H₂₆N₄O₄S 
• 1251158-62-9 C₂₇H₂₇N₃O₄S 
• 1251153-94-2 C₂₆H₂₅N₃O₄S 
• 1251154-30-9 C₂₅H₂₃N₃O₄S 

Relevant articles and documents

Synthesis, structure and properties of oxocyanido W(IV) complexes with substituted salicylaldimines of 2-aminoethanol compared to Mo(IV) analogs

A series of W(IV) complexes with 2-aminoethanol and 5-bromo-, 5-chloro-, 5-methoxy-, 3,5 -dichloro-substituted salicylaldehydes is described. The complexes were isolated and characterized by elemental analysis, IR and UV-Vis spectroscopy as well as cyclic

Synthesis, crystal structures, and antibacterial activity of cobalt and copper complexes with tridentate schiff bases

Three mononuclear cobalt and copper complexes, [Co(HL1) 2]·[Co(L1)2] (1), [Cu(HL 2)2] (2), and [CoL2(HL2)] 2 (3), where HL1 and HL2 ar

Mo(IV) and W(IV) cyanido complexes with Schiff bases. Synthesis, X-Ray single crystal structures, physicochemical properties and quantum chemical calculations

In the reaction of salicylaldehyde derivatives and aminoethanol with Mo(IV) or W(IV) cyanido complexes, six new salts were isolated and characterized by physicochemical measurements. The single crystal X-ray analysis of four salts of the formula (PPh

Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR)

A series of novel, highly potent, selective, and ATP-competitive mammalian target of rapamycin (mTOR) inhibitors based on a benzoxazepine scaffold have been identified. Lead optimization resulted in the discovery of inhibitors with low nanomolar activity and greater than 1000-fold selectivity over the closely related PI3K kinases. Compound 28 (XL388) inhibited cellular phosphorylation of mTOR complex 1 (p-p70S6K, pS6, and p-4E-BP1) and mTOR complex 2 (pAKT (S473)) substrates. Furthermore, this compound displayed good pharmacokinetics and oral exposure in multiple species with moderate bioavailability. Oral administration of compound 28 to athymic nude mice implanted with human tumor xenografts afforded significant and dose-dependent antitumor activity.

Synthesis and structural studies on bis-N-(2-hydroxyethyl)-X-salicylaldiminato complexes of cobalt(III) and copper(II)

Spectroscopic properties and magnetic behaviours of the synthesised cobalt(III) and copper(II) complexes of the schiff bases N-(2-hydroxyethyl-X-salicylaldimines) (where X=H or 5Br) and the molecular structure of bis- (N2-hydroxyethylsalicylaldiminato) co